Review Article| Volume 21, ISSUE 10, P1439-1450.e21, October 2020

Download started.


Omega-3, Omega-6, and Polyunsaturated Fat for Cognition: Systematic Review and Meta-analysis of Randomized Trials



      Neurocognitive function may be influenced by polyunsaturated fat intake. Many older adults consume omega-3 supplements hoping to prevent cognitive decline. We assessed effects of increasing omega-3, omega-6, or total polyunsaturated fats on new neurocognitive illness and cognition.

      Design and inclusion criteria

      We carried out a systematic review and meta-analysis of randomized controlled trials (RCTs) in adults, with duration ≥24 weeks, assessing effects of higher vs lower omega-3, omega-6, or total polyunsaturated fats and outcomes: new neurocognitive illness, newly impaired cognition, and/or continuous measures of cognition.


      We searched MEDLINE, Embase, Cochrane CENTRAL, and trials registers (final update of ongoing trials December 2018). We duplicated screening, data extraction, and risk of bias assessment. Neurocognitive measures were grouped to enable random effects meta-analysis. GRADE assessment, sensitivity analyses, and subgrouping by dose, duration, type of intervention, and replacement were used to interrogate our findings.


      Searches generated 37,810 hits, from which we included 38 RCTs (41 comparisons, 49,757 participants). Meta-analysis suggested no or very little effect of long-chain omega-3 on new neurocognitive illness [risk ratio (RR) 0.98, 95% confidence interval (CI) 0.87-1.10, 6 RCTs, 33,496 participants, I2 36%), new cognitive impairment (RR 0.99, 95% CI 0.92-1.06, 5 RCTs, 33,296 participants, I2 0%) or global cognition assessed using the Mini-Mental State Examination (MD 0.10, 95% CI 0.03-0.16, 13 RCTs, 14,851 participants, I2 0%), all moderate-quality evidence. Effects did not differ with sensitivity analyses, and we found no differential effects by dose, duration, intervention type, or replacement. Effects of increasing α-linolenic acid, omega-6, or total PUFA were unclear.


      This extensive trial data set enabled assessment of effects on neurocognitive illness and cognitive decline not previously adequately assessed. Long-chain omega-3 probably has little or no effect on new neurocognitive outcomes or cognitive impairment.


      Long-chain omega-3 supplements do not help older adults protect against cognitive decline.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of the American Medical Directors Association
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Seitz D.
        • Purandare N.
        • Conn D.
        Prevalence of psychiatric disorders among older adults in long-term care homes: A systematic review.
        Int Psychogeriatr. 2010; 22: 1025-1039
        • Feldman H.
        • Clarfield A.M.
        • Brodsky J.
        • et al.
        An estimate of the prevalence of dementia among residents of long-term care geriatric institutions in the Jerusalem area.
        Int Psychogeriatr. 2006; 18: 643-652
        • Kenkmann A.
        • Price G.M.
        • Bolton J.
        • et al.
        Health, wellbeing and nutritional status of older people living in UK care homes: An exploratory evaluation of changes in food and drink provision.
        BMC Geriatr. 2010; 10: 28
        • Patterson C.
        World Alzheimer Report 2018: The State of the Art of Dementia Research, New Frontiers.
        Alzheimer's Disease International, London2018
        • WHO
        Dementia: A Public Health Priority.
        World Health Organization, Geneva2016
        • Lozano R.
        • Naghavi M.
        • Foreman K.
        • et al.
        Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010.
        Lancet. 2012; 380: 2095-2128
        • Feigin V.L.
        • Nichols E.
        • Alam T.
        • et al.
        Global, regional, and national burden of neurological disorders, 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016.
        Lancet Neurol. 2019; 18: 459-480
        • Cederholm T.
        Fish consumption and omega-3 fatty acid supplementation for prevention or treatment of cognitive decline, dementia or Alzheimer's disease in older adults—Any news?.
        Curr Opin Clin Nutr Metab Care. 2017; 20: 104-109
        • Devassy J.G.
        • Leng S.
        • Gabbs M.
        • et al.
        Omega-3 polyunsaturated fatty acids and oxylipins in neuroinflammation and management of Alzheimer disease.
        Adv Nutr. 2016; 7: 905-916
        • Song C.
        • Shieh C.H.
        • Wu Y.S.
        • et al.
        The role of omega-3 polyunsaturated fatty acids eicosapentaenoic and docosahexaenoic acids in the treatment of major depression and Alzheimer's disease: Acting separately or synergistically?.
        Prog Lipid Res. 2016; 62: 41-54
        • Papanikolaou Y.
        • Brooks J.
        • Reider C.
        • et al.
        U.S. adults are not meeting recommended levels for fish and omega-3 fatty acid intake: Results of an analysis using observational data from NHANES 2003–2008.
        Nutr J. 2014; 13: 31
        • Scientific Advisory Committee on Nutrition
        Committee on Toxicity. Advice on Fish Consumption: Benefits & Risks.
        Her Majesty's Stationery Office, London2004
        • World Health Organization
        Polychlorinated Bipheyls and Polybrominated Biphenyls.
        World Health Organization, Lyon, France2016
        • Vacchi-Suzzi C.
        • Karimi R.
        • Kruse D.
        • et al.
        Low-level mercury, omega-3 index and neurobehavioral outcomes in an adult US coastal population.
        Eur J Nutr. 2016; 55: 699-711
        • Wu S.
        • Ding Y.
        • Wu F.
        • et al.
        Omega-3 fatty acids intake and risks of dementia and Alzheimer's disease: A meta-analysis.
        Neurosci Biobehav Rev. 2015; 48: 1-9
        • Loef M.
        • Walach H.
        The omega-6/omega-3 ratio and dementia or cognitive decline: A systematic review on human studies and biological evidence.
        J Nutr Gerontol Geriatr. 2013; 32: 1-23
        • Sydenham E.
        • Dangour A.D.
        • Lim W.S.
        Omega 3 fatty acid for the prevention of cognitive decline and dementia.
        Cochrane Database Syst Rev. 2012; : CD005379
        • Abdelhamid A.S.
        • Brown T.J.
        • Brainard J.S.
        • et al.
        Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease.
        Cochrane Database Syst Rev. 2020; : CD003177
        • Abdelhamid A.S.
        • Martin N.
        • Bridges C.
        • et al.
        Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease.
        Cochrane Database Syst Rev. 2018; : CD012345
        • Hooper L.
        • Al-Khudairy L.
        • Abdelhamid A.S.
        • et al.
        Omega-6 fats for the primary and secondary prevention of cardiovascular disease.
        Cochrane Database Syst Rev. 2018; : CD011094
        • Brown T.J.
        • Brainard J.
        • Song F.
        • et al.
        Omega-3, omega-6, and total dietary polyunsaturated fat for prevention and treatment of type 2 diabetes mellitus: Systematic review and meta-analysis of randomised controlled trials.
        Br Med J. 2019; 366: l4697
        • Hooper L.
        • Abdelhamid A.
        • Brainard J.
        • et al.
        Creation of a database to assess effects of omega-3, omega-6 and total polyunsaturated fats on health: Database and methodology for a set of reviews.
        BMJ Open. 2019; 9: e029554
        • Abdelhamid A.
        • Hooper L.
        • Sivakaran R.
        • et al.
        The relationship between omega-3, omega-6 and total polyunsaturated fat and musculoskeletal health and functional status in adults: A systematic review and meta-analysis of RCTs.
        Calcif Tissue Int. 2019; 105: 353-372
        • Hanson S.
        • Thorpe G.
        • Winstanley L.
        • et al.
        Omega-3, omega-6 and total dietary polyunsaturated fat on cancer incidence: Systematic review and meta-analysis of randomised trials.
        Br J Cancer. 2020; 122: 1260-1270
        • Thorpe G.
        • Ajabnoor S.
        • Ahmed Z.
        • et al.
        Dietary polyunsaturated fat for prevention and treatment of inflammatory bowel disease.
        PROSPERO. 2017; (CRD42017068704)
        • Deane K.H.O.
        • Jimoh O.F.
        • Biswas P.
        • et al.
        Omega-3 and polyunsaturated fat for prevention of depression and anxiety symptoms: Systematic review and meta-analysis of randomised trials.
        Br J Psychiatry. 2019; : 1-8
        • Browning L.M.
        • Walker C.G.
        • Mander A.P.
        • et al.
        Incorporation of eicosapentaenoic and docosahexaenoic acids into lipid pools when given as supplements providing doses equivalent to typical intakes of oily fish.
        Am J Clin Nutr. 2012; 96: 748-758
        • Higgins J.P.T.
        • Altman D.G.
        • Sterne J.A.C.
        • et al.
        Assessing risk of bias in included studies.
        in: Higgins J.P.T. Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. The Cochrane Collaboration, Copenhagen2011
      1. Review Manager 5 (RevMan 5). The Nordic Cochrane Centre, The Cochrane Collaboration, Copenhagen2014
        • Egger M.
        • Davey Smith G.
        • Schneider M.
        • et al.
        Bias in meta-analysis detected by a simple graphical test.
        Br Med J. 1997; 315: 629-634
        • De Jager C.A.
        • Dye L.
        • De Bruin E.A.
        • et al.
        Criteria for validation and selection of cognitive tests for investigating the effects of foods and nutrients.
        Nutr Rev. 2014; 72: 162-179
        • Jiao J.
        • Li Q.
        • Chu J.
        • et al.
        Effect of n-3 PUFA supplementation on cognitive function throughout the life span from infancy to old age: A systematic review and meta-analysis of randomized controlled trials.
        Am J Clin Nutr. 2014; 100: 1422-1436
        • Yurko-Mauro K.
        • Alexander D.D.
        • Van Elswyk M.E.
        Docosahexaenoic acid and adult memory: A systematic review and meta-analysis.
        PLoS One. 2015; 10: e0120391
        • Quinn J.F.
        • Raman R.
        • Thomas R.G.
        • et al.
        Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: A randomized trial.
        JAMA. 2010; 304: 1903-1911
        • Geleijnse J.M.
        • Giltay E.J.
        • Kromhout D.
        Effects of n-3 fatty acids on cognitive decline: A randomized, double-blind, placebo-controlled trial in stable myocardial infarction patients.
        Alzheimers Dement. 2012; 8: 278-287
        • Kromhout D.
        • Giltay E.J.
        • Geleijnse J.M.
        • et al.
        n-3 fatty acids and cardiovascular events after myocardial infarction.
        N Engl J Med. 2010; 363: 2015-2026
        • Chew E.Y.
        • Clemons T.E.
        • Agron E.
        • et al.
        Effect of omega-3 fatty acids, lutein/zeaxanthin, or other nutrient supplementation on cognitive function: The AREDS2 randomized clinical trial.
        JAMA. 2015; 314: 791-801
        • Age-Related Eye Disease Study 2 Research Group
        Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: The Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial.
        JAMA. 2013; 309: 2005-2015
        • Ascend Study Collaborative Group
        Effects of n-3 fatty acid supplements in diabetes mellitus.
        N Engl J Med. 2018; 379: 1540-1550
        • Baleztena Gurrea J.
        • Ruiz-Canela M.
        • Pardo M.
        • et al.
        Utility of heavy food supplement in omega-3 fatty acids in the prevention of dementia, in relation to the basal nutritional level, in people of advanced age: Randomized multicenter study.
        Revista Española de Geriatría y Gerontología. 2015; 50: 1-49
        • Bo Y.
        • Zhang X.
        • Wang Y.
        • et al.
        The n-3 polyunsaturated fatty acids supplementation improved the cognitive function in the Chinese elderly with mild cognitive impairment: A double-blind randomized controlled trial.
        Nutrients. 2017; 9: E54
        • Boespflug E.L.
        • Mcnamara R.K.
        • Eliassen J.C.
        • et al.
        Fish oil supplementation increases event-related posterior cingulate activation in older adults with subjective memory impairment.
        J Nutr Health Aging. 2016; 20: 161-169
        • Chiu C.C.
        • Su K.P.
        • Cheng T.C.
        • et al.
        The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: A preliminary randomized double-blind placebo-controlled study.
        Prog Neuropsychopharmacol Biol Psychiatry. 2008; 32: 1538-1544
        • Burr M.L.
        • Fehily A.M.
        • Gilbert J.F.
        • et al.
        Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: Diet and reinfarction trial (DART).
        Lancet. 1989; 2: 757-761
        • Danthiir V.
        • Hosking D.
        • Burns N.R.
        • et al.
        Cognitive performance in older adults is inversely associated with fish consumption but not erythrocyte membrane n-3 fatty acids.
        J Nutr. 2014; 144: 311-320
        • Hashimoto M.
        • Yamashita K.
        • Kato S.
        • et al.
        Beneficial effects of daily dietary omega-3 polyunsaturated fatty acid supplementation on age related cognitive decline in elderly Japanese with very mild dementia: A 2-year randomized, double-blind, placebo-controlled trial.
        J Aging Res Clin Pract. 2012; 1: 193-201
        • Hashimoto M.
        • Kato S.
        • Tanabe Y.
        • et al.
        Beneficial effects of dietary docosahexaenoic acid intervention on cognitive function and mental health of the oldest elderly in Japanese care facilities and nursing homes.
        Geriatr Gerontol Int. 2016; 17: 330-337
        • Jackson P.A.
        • Forster J.S.
        • Bell J.G.
        • et al.
        DHA supplementation alone or in combination with other nutrients does not modulate cerebral hemodynamics or cognitive function in healthy older adults.
        Nutrients. 2016; 8: 86
        • Lee L.K.
        • Shahar S.
        • Chin A.V.
        • et al.
        Docosahexaenoic acid-concentrated fish oil supplementation in subjects with mild cognitive impairment (MCI): A 12-month randomised, double-blind, placebo-controlled trial.
        Psychopharmacology. 2013; 225: 605-612
        • Andrieu S.
        • Guyonnet S.
        • Coley N.
        • et al.
        Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): A randomised, placebo-controlled trial.
        Lancet Neurol. 2017; 16: 377-389
        • Van De Rest O.
        • Geleijnse J.M.
        • Kok F.J.
        • et al.
        Effect of fish oil on cognitive performance in older subjects: A randomized, controlled trial.
        Neurology. 2008; 71: 430-438
        • Yurko-Mauro K.
        • Mccarthy D.
        • Rom D.
        • et al.
        Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline.
        Alzheimers Dement. 2010; 6: 456-464
        • Garbagnati F.
        • Cairella G.
        • De Martino A.
        • et al.
        Is antioxidant and n-3 supplementation able to improve functional status in poststroke patients? Results from the Nutristroke Trial.
        Cerebrovasc Dis. 2009; 27: 375-383
        • Torkildsen O.
        • Wergeland S.
        • Bakke S.
        • et al.
        Omega-3 fatty acid treatment in multiple sclerosis (OFAMS Study): A randomized, double-blind, placebo-controlled trial.
        Arch Neurol. 2012; 69: 1044-1051
        • Freund Levi Y.
        • Eriksdotter-Jönhagen M.
        • Cederholm T.
        • et al.
        Omega-3 fatty acid treatment of 174 patients with mild to moderate Alzheimer’s disease (OmegAD): A randomized double-blind trial.
        Arch Neurol. 2006; 63: 1402-1408
        • Freund-Levi Y.
        • Basun H.
        • Cederholm T.
        • et al.
        Omega-3 supplementation in mild to moderate Alzheimer's disease: Effects on neuropsychiatric symptoms.
        Int J Geriatr Psychiatry. 2008; 23: 161-169
        • Freund-Levi Y.
        • Hjorth E.
        • Lindberg C.
        • et al.
        Effects of omega-3 fatty acids on inflammatory markers in cerebrospinal fluid and plasma in Alzheimer's disease: The OmegAD study.
        Dement Geriatr Cogn Disord. 2009; 27: 481-490
        • Dangour A.D.
        • Allen E.
        • Elbourne D.
        • et al.
        Effect of 2-y n-3 long-chain polyunsaturated fatty acid supplementation on cognitive function in older people: A randomized, double-blind, controlled trial.
        Am J Clin Nutr. 2010; 91: 1725-1732
        • ORIGIN Trial Investigators
        • Bosch J.
        • Gerstein H.C.
        • et al.
        n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia.
        N Engl J Med. 2012; 367: 309-318
        • Paty D.W.
        • Cousin H.K.
        • Read S.
        • Adlakha K.
        Linoleic acid in multiple sclerosis: Failure to show any therapeutic benefit.
        Acta Neurol Scand. 1978; 58: 53-58
        • Pomponi M.
        • Loria G.
        • Salvati S.
        • et al.
        DHA effects in Parkinson disease depression.
        Basal Ganglia. 2014; 4: 61-66
        • Estruch R.
        • Ros E.
        • Salas-Salvadó J.
        • et al.
        Retraction and republication: Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med 2013;368:1279-1290.
        N Engl J Med. 2018; 378: 2441-2442
        • Martinez-Lapiscina E.H.
        • Clavero P.
        • Toledo E.
        • et al.
        Mediterranean diet improves cognition: The PREDIMED-NAVARRA randomised trial.
        J Neurol Neurosurg Psychiatry. 2013; 84: 1318-1325
        • Valls-Pedret C.
        • Sala-Vila A.
        • Serra-Mir M.
        • et al.
        Mediterranean diet and age-related cognitive decline: A randomized clinical trial.
        JAMA Intern Med. 2015; 175: 1094-1103
        • Puri B.K.
        • Leavitt B.R.
        • Hayden M.R.
        • et al.
        Ethyl-EPA in Huntington disease: A double-blind, randomized, placebo-controlled trial.
        Neurology. 2005; 65: 286-292
        • Raitt M.H.
        • Connor W.E.
        • Morris C.
        • et al.
        Fish oil supplementation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable defibrillators: A randomized controlled trial.
        JAMA. 2005; 293: 2884-2891
        • Rebello C.J.
        • Keller J.N.
        • Liu A.G.
        • et al.
        Pilot feasibility and safety study examining the effect of medium chain triglyceride supplementation in subjects with mild cognitive impairment: A randomized controlled trial.
        BBA Clin. 2015; 3: 123-125
        • Romero Imbroda J.
        The role of omega-3 fatty acids in patients with mild cognitive impairment by means of the PHOTOTEST.
        J Neurol Sci. 2013; 333: e610
        • Schättin A.
        Influence of exergame training and its combination with omega-3 fatty acids on the elderly brain.
        (PhD thesis) ETH Zurich, Zurich2017
        • Von Schacky C.
        • Angerer P.
        • Kothny W.
        • et al.
        The effect of dietary omega-3 fatty acids on coronary atherosclerosis. A randomized, double-blind, placebo-controlled trial.
        Ann Intern Med. 1999; 130: 554-562
        • Shinto L.
        • Quinn J.
        • Montine T.
        • et al.
        A randomized placebo-controlled pilot trial of omega-3 fatty acids and alpha lipoic acid in Alzheimer's disease.
        J Alzheimers Dis. 2014; 38: 111-120
        • Sinn N.
        • Milte C.M.
        • Street S.J.
        • et al.
        Effects of n-3 fatty acids, EPA v. DHA, on depressive symptoms, quality of life, memory and executive function in older adults with mild cognitive impairment: A 6-month randomised controlled trial.
        Br J Nutr. 2012; 107: 1682-1693
        • Stonehouse W.
        • Conlon C.A.
        • Podd J.
        • et al.
        DHA supplementation improved both memory and reaction time in healthy young adults: A randomized controlled trial.
        Am J Clin Nutr. 2013; 97: 1134-1143
        • Andreeva V.A.
        • Kesse-Guyot E.
        • Barberger-Gateau P.
        • et al.
        Cognitive function after supplementation with B vitamins and long-chain omega-3 fatty acids: Ancillary findings from the SU.FOL.OM3 randomized trial.
        Am J Clin Nutr. 2011; 94: 278-286
        • Galan P.
        • Briancon S.
        • Blacher J.
        • et al.
        The SU.FOL.OM3 Study: A secondary prevention trial testing the impact of supplementation with folate and B-vitamins and/or Omega-3 PUFA on fatal and non fatal cardiovascular events, design, methods and participants characteristics.
        Trials. 2008; 9: 35
        • Galan P.
        • Kesse-Guyot E.
        • Czernichow S.
        • et al.
        Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: A randomised placebo controlled trial.
        Br Med J. 2010; 341: c6273
        • Terano T.
        • Fujishiro S.
        • Ban K.
        • et al.
        Docosahexaenoic acid supplementation improves the moderately severe dementia from thrombotic cerebrovascular diseases.
        Lipids. 1999; 34: S345-S346
        • Zhang Y.P.
        • Miao R.
        • Li Q.
        • et al.
        Effects of DHA supplementation on hippocampal volume and cognitive function in older adults with mild cognitive impairment: A 12-month randomized, double-blind, placebo-controlled trial.
        J Alzheimers Dis. 2016; 55: 497-507
        • Folstein M.F.
        • Folstein S.E.
        • McHugh P.R.
        “Mini-Mental State”: A practical method for grading the cognitive state of patients for the clinician.
        J Psychiatr Res. 1975; 12: 189-198
        • Zhang X.W.
        • Hou W.S.
        • Li M.
        • et al.
        Omega-3 fatty acids and risk of cognitive decline in the elderly: A meta-analysis of randomized controlled trials.
        Aging Clin Exp Res. 2016; 28: 165-166
        • Shah R.
        The role of nutrition and diet in Alzheimer disease: A systematic review.
        J Am Med Dir Assoc. 2013; 14: 398-402
        • Muñoz Fernández S.S.
        • Ivanauskas T.
        • Lima Ribeiro S.M.
        Nutritional strategies in the management of Alzheimer disease: Systematic review with network meta-analysis.
        J Am Med Dir Assoc. 2017; 18: 897.e13-897.e30
        • Butler M.
        • Nelson V.A.
        • Davila H.
        • et al.
        Over-the-counter supplement interventions to prevent cognitive decline, mild cognitive impairment, and clinical Alzheimer-type dementia: A systematic review.
        Ann Intern Med. 2018; 168: 52-62
        • Burckhardt M.
        • Herke M.
        • Wustmann T.
        • et al.
        Omega-3 fatty acids for the treatment of dementia.
        Cochrane Database Syst Rev. 2016; : CD009002
        • Tombaugh T.N.
        • Mcintyre N.J.
        The Mini-Mental State Examination: A comprehensive review.
        J Am Geriatr Soc. 1992; 40: 922-935
        • Kang J.H.
        A large randomized trial of vitamin D, omega-3 fatty acids and cognitive decline (VITAL-Cog).
        (Available at:) (Accessed November 27, 2019)

      Related Podcast

      October 8, 2020

      October 2020 Issue

      Featuring Dr. Philip Sloane, Dr. Mallory Brown; Recorded: October 16, 2020. 

      Loading ...